The prognosis for MALT lymphoma depends on the particular type of MALT lymphoma, but the outlook is good, with approximately 80 percent of patients cancer-free at five years and 77 percent cancer-free at 10 years, according to the Lymphoma Foundation. Patients infected with Helicobacter pylori receive the H. pylori eradication treatment, which results in 70 to 80 percent of patients in stage one and stage two successfully entering into remission, reports the Clinical Gastroenterology journal.
MALT lymphoma stands for mucosa-associated lymphoid tissue lymphoma, and the disease is the third most common type amongst non-Hodgkin lymphoma diseases, notes the Leukaemia Foundation. MALT lymphoma is most commonly present in people who are age 60 or older and is more common in women. The disease affects people of all ethnic groups, and risk factors, apart from the presence of H. pylori, are not yet known, according to the Lymphoma Foundation. The disease enters the body through the mucosa that lines the body cavities, such as the stomach, lungs, skin, thyroid gland, eyes, salivary glands and breasts.
Treatments are chosen based on the type of MALT lymphoma as well as the patient's medical history and the stage of the patient's disease, according to the Leukaemia Foundation. Radiation therapy, chemotherapy, surgery and single-agent chemotherapy treatments are all possible treatment options. Doctors may also prescribe antibiotics and ranitidine to lower the production of stomach acid and to help keep patients with gastric MALT lymphoma in remission.